Trial · NCT01372995
Registered outcomes14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 14 of 14
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of Participants With Plasma 25(OH)D Concentration >30ng/mL at Baseline | Baseline | The number of participants with a plasma 25(OH)D concentration in the desirable range (defined as greater than 30 ng/mL) at the baseline measurement. |
| Primary | Number of Participants With Plasma 25(OH)D Concentration >30ng/mL at Day 7 | Day 7 | The number of participants with a plasma 25(OH)D concentration in the desirable range (defined as greater than 30 ng/mL) at the Day 7 measurement. |
| Primary | Number of Participants With Plasma 25(OH)D Concentration >30ng/mL at Day 14 | Day 14 | The number of participants with a plasma 25(OH)D concentration in the desirable range (defined as greater than 30 ng/mL) at the Day 14 measurement. |
| Primary | Number of Participants With Plasma 25(OH)D Concentration >30ng/mL at Day 21 | Day 21 | The number of participants with a plasma 25(OH)D concentration in the desirable range (defined as greater than 30 ng/mL) at the Day 21 measurement. |
| Primary | Number of Participants With Plasma 25(OH)D Concentration >30ng/mL at Day 28 | Day 28 | The number of participants with a plasma 25(OH)D concentration in the desirable range (defined as greater than 30 ng/mL) at the Day 28 measurement. |
| Primary | Number of Participants With Plasma 25(OH)D Concentration >30ng/mL at Day 84 | Day 84 | The number of participants with a plasma 25(OH)D concentration in the desirable range (defined as greater than 30 ng/mL) at the Day 84 measurement. |
| Secondary | Change in Plasma LL-37 Levels | Baseline, Day 7, Day 14 | Plasma LL-37 was measured at Baseline, Day 7 and Day 14. |
| Secondary | Duration of Time on Ventilator | 12 weeks | The number of days spent on mechanical ventilation was collected for all study participants and the average number of days for each study arm is reported. |
| Secondary | Duration of Time in Intensive Care Unit (ICU) | 12 weeks | The number of days spent in the intensive care unit (ICU) was collected for each participant and the average number of days for each study arm is reported. |
| Secondary | Duration of Time in Hospital | 12 weeks | The number of days that each participant spent in the hospital was collected and the average number of days for each study arm is reported. |
| Secondary | Change in Sequential Organ Failure Assessment (SOFA) Score | Baseline, Day 7 | Change in Sequential Organ Failure Assessment (SOFA) score between Baseline and Day 7. The Sequential Organ Failure Assessment (SOFA) score is a mortality prediction score that is based on the degree of dysfunction of 6 organ systems (respiratory, nervous, cardiovascular, liver, coagulation, and kidneys). A score ranges from 0-24. 0 (normal) to 4 (high degree of dysfunction) is given for each organ system, with a higher score indicating greater severity. A score of 0-6 is associated with a mortality rate of less than 10% while a score between 16 and 24 is associated with a greater than 90% mortality rate. Scores decreasing between the Baseline and Day 7 measurements are represented as negative values for the change in SOFA score. |
| Secondary | Number of Hospital Acquired Infections | 12 weeks | The number of study participants who had a hospital acquired infection. |
| Secondary | Number of Hospital Mortality Cases | 12 weeks | The number of study participants who died while in the hospital was collected. |
| Secondary | Day 84 Mortality | Day 84 | The number of participants who died prior to the end of the study (Day 84) was collected. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01372995/registered